Key result
A 10-day bromocriptine regimen plus standard therapy reduces HF manifestations in a PPCM case.
Case Report (n=1)
No
A case report illustrating the successful treatment of severe peripartum cardiomyopathy using standard heart failure therapy combined with bromocriptine.
Supports adjunctive bromocriptine in peripartum cardiomyopathy; hypothesis-generating and should not change practice.
A 35-year-old patient, a native of Uzbekistan, had shortness of breath and swelling of the lower extremities at the 35th week of the fourth pregnancy. She gave birth at the 39th gestational week naturally. Symptoms progressed within 3 months after delivery: ascites and hydrothorax appeared. According to echocardiography, dilation of the heart chambers was detected, the left ventricular ejection fraction was 30%. A diagnosis of peripartal cardiomyopathy (CMP) complicated by CHF third degree was established. During 10 days of treatment, the manifestations of HF decreased significantly.
No takes yet. Share an insight, caveat, or question.
Dadabayeva et al. (2023) conducted a case report in Peripartal cardiomyopathy (n=1). Bromocriptine and standard heart failure therapy was evaluated on Improvement of heart failure manifestations. A 10-day treatment regimen including bromocriptine and standard heart failure therapy significantly reduced manifestations of heart failure in a 35-year-old woman with peripartal cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: